Inactive Instrument

News CannaVEST Corp OTC Bulletin Board

Stocks

US1376531018

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

08-13	CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026
08-13	CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

All News

Mentions Relevance

09-09	CV Sciences : Initial Statement of Beneficial Ownership (Form 3)	PU
09-08	CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework	AQ
08-13	CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026
08-13	CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-13	CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results	AQ
08-11	CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids	AQ
08-10	CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026	AQ
06-25	CV Sciences Expands +PlusHLTH(TM) Portfolio with Personalized Wellness Solutions for Healthy Aging	AQ
06-02	CV Sciences, Inc. - Shareholder/Analyst Call
05-14	CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026
05-14	CV Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-14	CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results	AQ
05-12	CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026	AQ
03-26	CV Sciences, Inc., Q4 2025 Earnings Call, Mar 26, 2026
03-26	CV Sciences Seeks M&A	CI
03-26	CV Sciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
03-26	CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results	AQ
03-25	CV Sciences, Inc. Auditor Raises 'Going Concern' Doubt	CI
03-24	CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026	AQ
11-13	CV Sciences, Inc., Q3 2025 Earnings Call, Nov 13, 2025
11-13	CV Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-13	CV Sciences Q3 revenue falls	RE
25-10-05	CV Sciences, Inc. announced that it has received $3 million in funding	CI
25-09-11	CV Sciences, Inc. announced that it has received $1.2 million in funding	CI
25-08-13	CV Sciences, Inc., Q2 2025 Earnings Call, Aug 13, 2025